Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

J&J agrees $30bn deal to acquire Actelion

J&J agrees $30bn deal to acquire Actelion ACT-132577, an Actelion candidate for resistant hypertension that is currently in phase II clinical development. ... Analysts at Jefferies have said they do not expect any other drugmaker to come in with a counter offer for Actelion.

J&J pondering future of diabetes device assets

J&J pondering future of diabetes device assets J&J is in the midst of negotiating a possible takeover of Swiss biotech Actelion, but gave no update on that process in its fourth-quarter presentations.

Actelion reports late-stage trial failure as J&J talks continue

Actelion reports late-stage trial failure as J&J talks continue Actelion also has a third PAH drug - Uptravi (selexipag) - that has grown quickly since its launch and is predicted to hit $1bn in sales by 2020. ... Actelion started negotiating with J&J about a possible takeover last November, only to reject the US

Dr Michael Mehler joins leon-nanodrugs as CEO

Dr Michael Mehler joins leon-nanodrugs as CEO Prior to this, he was chief executive officer of Riemser Pharma, and held a number of positions at Actelion Pharmaceuticals, Merck &Co and Novartis.

J&J back in frame to buy Actelion after Sanofi talks break down

J&J back in frame to buy Actelion after Sanofi talks break down shareholders a further return on top of the purchase price if Actelion's pipeline delivers as promised.  . ... Actelion shares rose sharply yesterday as reports involving both Sanofi and J&J emerged.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics